Hiromitsu Kumada

903 citations

22 papers · 583 indexed · h-index 9

Hepatology top 2%
- Hepatitis C virus research 13
- Hepatocellular Carcinoma Treatment and Prognosis 7
Epidemiology
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 6
Surgery
Cancer Research
Oncology
- Cancer Treatment and Pharmacology 2
Infectious Diseases
- HIV/AIDS drug development and treatment 3
Genetics
- Chronic Lymphocytic Leukemia Research 2
Rheumatology
- Systemic Lupus Erythematosus Research 2

Co-authors: Kazuaki Chayama Yasuji Arase Satoshi Saitoh Akihito Tsubota Masahiko Tsurumaru Kenji Ikeda Goro Watanabe Masahiro Kobayashi
Cited by: Hepatology Epidemiology Surgery
Journals: Journal of Clinical Oncology (2 papers)Cancer (3 papers)Journal of Clinical Microbiology (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Hiromitsu Kumada

19 papers receiving 561 citations

Peers

Countries citing papers authored by Hiromitsu Kumada

Since Specialization

Citations

This map shows the geographic impact of Hiromitsu Kumada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Kumada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Kumada more than expected).

Fields of papers citing papers by Hiromitsu Kumada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Kumada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Kumada. The network helps show where Hiromitsu Kumada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiromitsu Kumada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiromitsu Kumada Line = papers co-authored together Hiromitsu Kumada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report Hepatology Research ·Yusuke Kawamura,Norio Akuta,(unknown),Masaru Matsumura,S. Okubo,Licht Tominaga,Shigeki Yamamoto,Yasuka Eriksson,Tetsuya Hosaka,Satoshi Saitoh,Hitomi Sezaki,Fumitaka Suzuki,Yoshiyuki Suzuki,Kenji Ikeda,Yasuji Arase,Masaji Hashimoto,Takuyo Kozuka,Hiromitsu Kumada	2025	0
2	Lenvatinib plus pembrolizumab versus lenvatinib alone as first-line therapy for advanced hepatocellular carcinoma: Longer-term efficacy and safety results from the phase 3 LEAP-002 study. Journal of Clinical Oncology ·Richard S. Finn,Masatoshi Kudo,Philippe Merle,Tim Meyer,Shukui Qin,Masafumi Ikeda,Ruocai Xu,Julien Edeline,Baek‐Yeol Ryoo,Zhenggang Ren,Ann‐Lii Cheng,Peter R. Galle,Shuichi Kaneko,Hiromitsu Kumada,Anran Wang,Kalgi Mody,Leonid Dubrovsky,Abby B. Siegel,Josep M. Llovet	2024	6
3	Health-related quality of life (HRQoL) impact of lenvatinib (len) plus pembrolizumab (pembro) versus len plus placebo (pbo) as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC): Phase 3 LEAP-002 study. Journal of Clinical Oncology ·Josep M. Llovet,Masatoshi Kudo,Philippe Merle,Tim Meyer,Shukui Qin,Masafumi Ikeda,Ruocai Xu,Julien Edeline,Baek‐Yeol Ryoo,Zhenggang Ren,Ann‐Lii Cheng,Peter R. Galle,Shuichi Kaneko,Hiromitsu Kumada,Shital Kamble,Josephine M. Norquist,Kalgi Mody,Leonid Dubrovsky,Abby B. Siegel,Richard S. Finn	2023	1
4	Pooled analysis of HCV genotype 1 resistance-associated substitutions in NS5A, NS3 and NS5B pre- and post-treatment with 12 weeks of daclatasvir, asunaprevir and beclabuvir Antiviral Therapy ·Fiona McPhee,Dennis Hernandez,Nannan Zhou,Joseph Ueland,Fei Yu,Vincent Vellucci,Xin Huang,Xuning Wang,Hiroki Ishikawa,Yoshiyasu Karino,Hiromitsu Kumada	2017	1
5	Rapid and high sensitive detection of Y93H amino acid substitution in HCV NS5A region using the PCR-Invader assay Kanzo ·Kenichi Tadokoro,Fumitaka Suzuki,Mariko Kobayashi,Yusuke Kawamura,Hitomi Sezaki,Tetsuya Hosaka,Norio Akuta,Masahiro Kobayashi,Yoshiyuki Suzuki,Satoshi Saitoh,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	2014	12
6	Utility of Detection of Telaprevir-Resistant Variants for Prediction of Efficacy of Treatment of Hepatitis C Virus Genotype 1 Infection Journal of Clinical Microbiology ·Norio Akuta,Fumitaka Suzuki,Taito Fukushima,Yusuke Kawamura,Hitomi Sezaki,Yoshiyuki Suzuki,Tetsuya Hosaka,Masahiro Kobayashi,Tasuku Hara,Mariko Kobayashi,Satoshi Saitoh,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	2013	13
7	Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis Kanzo ·Norihiro Imai,Kenji Ikeda,Yuya Seko,Miharu Hirakawa,Yusuke Kawamura,Tetsuya Hosaka,Masahiro Kobayashi,Satoshi Saitoh,Hitomi Sezaki,Norio Akuta,Fumitaka Suzuki,Yoshiyuki Suzuki,Yasuji Arase,Hiromitsu Kumada	2010	1
8	Relationship between SNPs in the IL28B region and amino acid substitutions in HCV core region in Japanese patients with chronic hepatitis C Kanzo ·Mariko Kobayashi,Fumitaka Suzuki,Norio Akuta,Yoshiyuki Suzuki,Hitomi Sezaki,Hiromi Yatsuji,Tetsuya Hosaka,Masahiro Kobayashi,Yusuke Kawamura,Miharu Hirakawa,Yasuji Arase,Kenji Ikeda,Rie Mineta,Satomi Iwasaki,Sachiyo Watahiki,Yusuke Nakamura,Kazuaki Chayama,Hiromitsu Kumada	2010	3
9	Efficacy and Safety of Combination Therapy of Natural Human Interferon .BETA. and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load Internal Medicine ·Yasuji Arase,Fumitaka Suzuki,Norio Akuta,Hitomi Sezaki,Yoshiyuki Suzuki,Yusuke Kawamura,Masahiro Kobayashi,Tetsuya Hosaka,Hiromi Yatsuji,Miharu Hirakawa,Naoki Matsumoto,Satoshi Saito,Kenji Ikeda,Mariko Kobayashi,Hiromitsu Kumada	2010	8
10	Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil Intervirology ·Norio Akuta,Fumitaka Suzuki,Yusuke Kawamura,Hiromi Yatsuji,Hitomi Sezaki,Yoshiyuki Suzuki,Tetsuya Hosaka,Masahiro Kobayashi,Mariko Kobayashi,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	2008	12
11	Low density lipoprotein cholesterol levels and amino acid substitutions in HCV core region are important pretreatment predictors of response to treatment with peginterferon plus ribavirin in Japanese patients with chronic hepatitis C Kanzo ·Norio Akuta,Fumitaka Suzuki,Yusuke Kawamura,Hiromi Yatsuji,Hitomi Sezaki,Yoshiyuki Suzuki,Tetsuya Hosaka,Masahiro Kobayashi,Mariko Kobayashi,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	2006	1
12	Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis Journal of Gastroenterology ·Naoya Murashima,Kenji Ikeda,Masahiro Kobayashi,Satoshi Saitoh,Kazuaki Chayama,Akihito Tsubota,Yoshiyuki Suzuki,Fumitaka Suzuki,Yasuji Arase,Hiromitsu Kumada	2001	9
13	Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma Journal of Gastroenterology ·Kenji Ikeda,Satoshi Saitoh,Masahiro Kobayashi,Yoshiyuki Suzuki,Fumitaka Suzuki,Akihito Tsubota,Yasuji Arase,Kazuaki Chayama,Naoya Murashima,Hiromitsu Kumada	2000	7
14	Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis Cancer ·Masahiro Kobayashi,Kenji Ikeda,Satoshi Saitoh,Fumitaka Suzuki,Akihito Tsubota,Yoshiyuki Suzuki,Yasuji Arase,N Murashima,Kazuaki Chayama,Hiromitsu Kumada	2000	193
15	Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course Journal of Gastroenterology ·Yasuji Arase,Kenji Ikeda,Kazuaki Chayama,Naoya Murashima,Akihito Tsubota,Yoshiyuki Suzuki,Satoshi Saitoh,Masahiro Kobayashi,Mariko Kobayashi,Fumitaka Suzuki,Hiromitsu Kumada	2000	8
16	Time Course of Histological Changes in Patients With A Sustained Biochemical and Virological Response to Corticosteroid Withdrawal Therapy for Chronic Hepatitis B The American Journal of Gastroenterology ·Yasuji Arase,Kenji Ikeda,Naoya Murashima,Kazuaki Chayama,Akihito Tsubota,Isao Koida,Yoshiyuki Suzuki,Satoshi Saitoh,Masahiro Kobayashi,Mizuho Kobayashi,Mariko Kobayashi,Hiromitsu Kumada	1999	4
17	Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology ·Akihito Tsubota,Hiromitsu Kumada,Yasuji Arase,Kazuaki Chayama,Satoshi Saitoh,Kenji Ikeda,Masahiro Kobayashi,Yoshiyuki Suzuki,Naoya Murashima	1999	47
18	Hepatitis C virus subtype 3b infection in a hospital in Japan: Epidemiological study Journal of Gastroenterology ·Kenji Ikeda,Kazuaki Chayama,Satoshi Saitoh,Isao Koida,Yoshiyuki Suzuki,Akihito Tsubota,Masahiro Kobayashi,Yasuji Arase,Naoya Murashima,Hiromitsu Kumada	1996	4
19	Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas Cancer ·Satoshi Saitoh,K Ikeda,Isao Koida,Akihito Tsubota,Yasuji Arase,Kazuaki Chayama,Hiromitsu Kumada	1994	26
20	Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma Cancer ·Kenji Ikeda,Satoshi Saitoh,Akihito Tsubota,Yasuji Arase,Kazuaki Chayama,Hiromitsu Kumada,Goro Watanabe,Masahiko Tsurumaru	1993	226

About Hiromitsu Kumada

Hiromitsu Kumada is a scholar working on Hepatology, Epidemiology and Genetics, having authored 22 papers that have together received 583 indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Hepatitis B Virus Studies (6 papers), HIV/AIDS drug development and treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Hepatology (368 citations), Epidemiology (236 citations) and Surgery (247 citations). Hiromitsu Kumada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kazuaki Chayama, Yasuji Arase, Satoshi Saitoh, Akihito Tsubota, Masahiko Tsurumaru, Kenji Ikeda, Goro Watanabe, Masahiro Kobayashi, Fumitaka Suzuki and Yoshiyuki Suzuki. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact